Pharmafile Logo

CP Kelco UK Ltd

CP Kelco is the innovation leader in the production of polysaccharides by microbial fermentation, extraction from land and sea plants, and modification of cellulose-based raw materials. CP Kelco’s goal is to be the preferred partner for providing innovative products and solutions through the use of nature-based chemistry.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Cleeve Court, Cleeve Road, Leatherhead, Surrey, KT22 7UD
+44  (0) 1372 369 400

 Latest Content from PMHub 

Modern Medical Affairs: How to Leverage Tech and Data as an MSL

Videos and Podcasts | September 29, 2022 | Impetus Digital

Dr. Luca Dezzani, VP of US Oncology Medical Affairs at Johnson & Johnson, explores innovation in Medical Affairs, new technologies for data dissemination and medical education, how to engage with...

The Creative Engagement Group appoints Tom Griffiths from Saatchi & Saatchi Wellness as Strategy and Planning Director

The Creative Engagement Group has appointed experienced healthcare and digital strategist Tom Griffiths.

Is communication failing us?

Compelling people to care in a world oversaturated with news and information

Are your field teams ready to excel in the new era?

A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs.

5 Healthcare Marketing Blunders | How To Avoid Them.

Here are 5 healthcare marketing blunders and how best to avoid them.

Design Trends We’ve Seen In 2022

Our graphic designer Isla takes a deep dive into the graphic design trends we’ve seen in 2022 and what to expect throughout 2023 and beyond.

Rare diseases: making a difference through education

Press Releases | September 28, 2022 | Medscape Education

Medscape Education team up with The Guardian to launch a Rare Disease campaign in the UK.

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment

Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?

Value is in the eye of the customer. Co-creation is a bridge to value.

White Papers and Resources | September 27, 2022 | nzyme

We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning.  Our interviews reveal important insights about the tensions between...